PRCT Financials: Procept Biorobotics Corp AI Analysis



Financials

PRCT Financial

Procept Biorobotics Corp

$24.63

2.45%

$0.58

At close: May 01, 16:00:00 GMT-4

$24.85

0.89%

$0.22

Post-market: May 01, 20:00:00 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$24.04

Open

$24.41

Day's Range

$23.21 - $24.99

52 week range

$19.35 - $66.85

Volume

1.2M

Avg.Volume

1.6M

Dividend yield

EPS (TTM)

-1.72

Market Cap

$1.4B

What is PRCT?

PROCEPT BioRobotics Corp. is a commercial-stage surgical robotics company, which engages in the development of transformative solutions in urology. The company is headquartered in San Jose, California and currently employs 756 full-time employees. The company went IPO on 2021-09-15. The firm is focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The firm's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.

Features

Markets

News

Income

Balance sheet

Cash flow

Annual

Quarterly

PRCT Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2025	09/30/2025	06/30/2025	03/31/2025	12/31/2024
Revenue	308	76	83	79	69	68
Revenue Growth (YoY)	38%	12%	43%	49%	56.99%	57.99%
Cost of Revenue	111	30	29	27	25	24
Gross Profit	196	46	54	51	44	43
Selling, General & Admin	228	58	59	56	55	48
Research & Development	71	19	18	17	16	15
Operating Expenses	300	77	77	73	71	63
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-95	-29	-21	-19	-24	-18
Income Tax Expense	0	0	--	--	--	--
Net Income	-95	-29	-21	-19	-24	-18
Net Income Growth	4%	61%	5%	-24%	-4%	-33%
Shares Outstanding (Diluted)	56.07	56.07	55.72	55.44	54.91	53.85
Shares Change (YoY)	4%	4%	7%	7%	8%	6%
EPS (Diluted)	-1.72	-0.53	-0.38	-0.35	-0.45	-0.35
EPS Growth	2%	52%	-5%	-28.99%	-12%	-36%
Free Cash Flow	-58	-12	-9	-17	-18	-33
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	63.63%	60.52%	65.06%	64.55%	63.76%	63.23%
Operating Margin	-33.44%	-40.78%	-27.71%	-27.84%	-39.13%	-27.94%
Profit Margin	-30.84%	-38.15%	-25.3%	-24.05%	-34.78%	-26.47%
Free Cash Flow Margin	-18.83%	-15.78%	-10.84%	-21.51%	-26.08%	-48.52%
EBITDA	-97	-30	-22	-21	-26	-18
EBITDA Margin	-31.49%	-39.47%	-26.5%	-26.58%	-37.68%	-26.47%
D&A For EBITDA	6	1	1	1	1	1
EBIT	-103	-31	-23	-22	-27	-19
EBIT Margin	-33.44%	-40.78%	-27.71%	-27.84%	-39.13%	-27.94%
Effective Tax Rate	0%	0%	--	--	--	--

Follow-Up Questions

What are Procept Biorobotics Corp's key financial statements?



According to the latest financial statement (Form-10K), Procept Biorobotics Corp has a total asset of $0, Net loss of $0

What are the key financial ratios for PRCT?



Procept Biorobotics Corp's Current ratio is 0, has a Net margin is 0, sales per share of $0.

How is Procept Biorobotics Corp's revenue broken down by segment or geography?



Procept Biorobotics Corp largest revenue segment is Hand Pieces and Other Consumables, at a revenue of 121,456,000 in the most earnings release.For geography, United States is the primary market for Procept Biorobotics Corp, at a revenue of 200,472,000.

Is Procept Biorobotics Corp profitable?



no, according to the latest financial statements, Procept Biorobotics Corp has a net loss of $0

Does Procept Biorobotics Corp have any liabilities?



no, Procept Biorobotics Corp has liability of 0

How many outstanding shares for Procept Biorobotics Corp?



Procept Biorobotics Corp has a total outstanding shares of 0

Procept Biorobotics Corp (PRCT) Financial

PRCT Stock Price Chart